INSM
Insmed Inc
NASDAQ: INSM · HEALTHCARE · BIOTECHNOLOGY
$136.33
+0.96% today
Updated 2026-04-30
Market cap
$29.15B
P/E ratio
—
P/S ratio
48.06x
EPS (TTM)
$-6.42
Dividend yield
—
52W range
$64 – $213
Volume
2.3M
Insmed Inc (INSM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-210.50%
Operating margin
-94.60%
ROE
-249.30%
ROA
-29.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $991000.00 | $-56.14M | -50.35% | -5,486.68% | -5,664.88% |
| 2007 | $7.53M | $-19.96M | 92.35% | -271.47% | -265.13% |
| 2008 | $11.70M | $-15.67M | 100.00% | -123.18% | -133.92% |
| 2009 | $10.37M | $118.35M | 100.00% | -83.62% | 1,140.94% |
| 2010 | $6.92M | $-6.43M | 100.00% | -116.92% | -92.96% |
| 2011 | $4.42M | $-59.66M | 100.00% | -1,397.31% | -1,350.78% |
| 2012 | $0.00 | $-41.37M | — | — | — |
| 2013 | $11.50M | $-56.07M | -157.77% | -478.39% | -487.59% |
| 2014 | $11.50M | $-79.16M | -191.61% | -759.70% | -688.34% |
| 2015 | $0.00 | $-118.18M | — | — | — |
| 2016 | $0.00 | $-176.27M | — | — | — |
| 2017 | $0.00 | $-192.65M | — | — | — |
| 2018 | $9.84M | $-324.28M | 75.36% | -3,124.94% | -3,297.17% |
| 2019 | $136.47M | $-254.34M | 82.26% | -172.38% | -186.37% |
| 2020 | $164.41M | $-294.09M | 75.75% | -161.32% | -178.87% |
| 2021 | $188.46M | $-434.65M | 76.57% | -199.03% | -230.63% |
| 2022 | $245.36M | $-481.53M | 77.53% | -186.39% | -196.26% |
| 2023 | $305.21M | $-749.57M | 78.52% | -232.51% | -245.59% |
| 2024 | $363.71M | $-913.77M | 76.43% | -241.47% | -251.24% |
| 2025 | $606.42M | $-1.28B | 79.41% | -194.04% | -210.54% |